Effect of LY450139 on the Long Term Progression of Alzheimer's Disease

Clinical trial NCT00594568 · COMPLETED

Trial details

NCT number: NCT00594568
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2008-03-01
Primary completion: 2011-05-01
Enrollment: 1537

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.